50 completed, 22 unknown, 5 terminated, 4 not yet recruiting. 27 Phase 4, 25 Not applicable, 17 Phase 3, 13 Phase 2, 4 Phase 1.
Follow cetrorelix: new trials by email Literature Review of cetrorelix trials Research Report on cetrorelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A GnRH antagonist, MPA - Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation | Phase 3 | Not yet recruiting | ShangHai Ji Ai Genetics & IVF Institute | 204 | 2027-06-01 | 2026-11-09 |
| Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS) Ganirelix ; Cetrorelix, Medroxyprogesterone Acetate ; Micronized Progesterone, Linzagolix - Infertility, Female, Ovulation Induction | Not applicable | Not yet recruiting | Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) | 120 | 2026-09-01 | 2026-09-30 |
| Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI Drospirenone drug, Cetrorelix 0.25 mg - Poor Ovarian Reserve, Infertility (IVF Patients) | Phase 1 / Phase 2 | Not yet recruiting | Ahmed Saad | 100 | 2026-08-01 | 2026-07-30 |
| A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) Follitropin alfa/lutropin alfa (MBJ-0011), hMG, Cetrorelix acetate - Infertility | Phase 3 | Recruiting | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 266 | 2026-02-05 | 2026-10-29 |
| Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles. Control Group (A):, Test Group (B): - Assisted Reproductive Techniques | Phase 4 | Not yet recruiting | Trust Fertility Clinic | 230 | 2026-01-01 | 2026-01-20 |
| Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! Cetrorelix drug, Drospirenone drug - PCOS (Polycystic Ovary Syndrome) | Phase 1 / Phase 2 | Completed | Ahmed Saad | 50 | 2024-10-01 | 2025-01-22 |
| PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study) Dydrogesterone 10 mg, Cetrorelix 0.25 mg - Progestins Primed Ovarian Stimulation | Not applicable | Active not recruiting | Mỹ Đức Hospital | 626 | 2024-04-24 | 2026-03-20 |
| Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI Dydrogesterone Tablets, Cetrorelix - IVF, PCO | Phase 2 / Phase 3 | Completed | Beni-Suef University | 200 | 2024-01-01 | 2026-04-15 |
| Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome Progesterone, GnRH antagonist (Cetrorelix) - Controlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome | Completed | El Shatby University Hospital for Obstetrics and Gynecology | 100 | 2023-12-01 | 2025-02-25 | |
| Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures BG2109, Cetrorelix - Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation | Phase 2 | Unknown | Bio Genuine (Shanghai) Biotech Co., Ltd. | 240 | 2023-08-01 | 2023-07-27 |
| Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes Dydrogesterone, Cetrorelix acetate, Triptorelin - IVF | Phase 3 | Unknown | Beni-Suef University | 387 | 2023-07-15 | 2023-08-02 |
| Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient Progesterone antagonist, conventional antagonist protocol - Polycystic Ovary Syndrome, Infertility | Not applicable | Unknown | Fayoum University | 210 | 2023-06-01 | 2023-05-06 |
| Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal), Dydrogesterone - Infertility | Not applicable | Completed | Bezmialem Vakif University | 297 | 2023-03-15 | 2024-10-15 |
| Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI progestin primed ovarian stimulation protocol, dydrogesterone (Duphaston, Abbott), Cetrotide - Ovary Cyst, Fertility Issues | Not applicable | Unknown | Zagazig University | 79 | 2023-02-20 | 2023-03-02 |
| PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial Dydrogesterone Oral Tablet, Cetrorelix (Cetrotide) - PPOS, GnRH Antagonist | Phase 3 | Completed | Kasr El Aini Hospital | 328 | 2023-01-03 | 2025-03-11 |
| Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles Dydrogesterone Tablets, cetrorelix 0.25mg, human menopausal gonadotropin - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Not applicable | Unknown | Mansoura University | 200 | 2021-11-01 | 2021-11-09 |
| Testosterone and Neurovascular Control in Humans Cetrorelix Acetate, Testosterone gel - Healthy | Not applicable | Unknown | Western University, Canada | 20 | 2021-06-01 | 2021-03-26 |
| GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst Cetrorelix Acetate, Ganerelix Acetate - IVF, Ovarian Cysts | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-05-01 | 2021-10-13 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
Showing 20 of 84. Sign in to see all of them.
Infertility (33) · Polycystic Ovary Syndrome (11) · Infertility, Female (5) · Ovarian Hyperstimulation Syndrome (4) · Helping Behavior (3) · Obesity (3) · Endometriosis (2) · Leiomyoma (2) · Ovarian Cysts (2) · Pregnancy, Ectopic (2) · Prostatic Hyperplasia (2) · Aneuploidy (1) · Arthritis, Rheumatoid (1) · Diabetes Mellitus, Type 1 (1) · Embryo Loss (1)
Cairo University (6) · Damascus University (4) · Merck KGaA, Darmstadt, Germany (4) · ShangHai Ji Ai Genetics & IVF Institute (4) · University of Colorado, Denver (4) · AEterna Zentaris (2) · Ahmed Saad (2) · Assiut University (2) · Beni-Suef University (2) · ClinAmygate (2) · Ferring Pharmaceuticals (2) · Instituto Valenciano de Infertilidad, IVI VALENCIA (2) · Ain Shams University (1) · Andros Day Surgery Clinic (1) · Aristotle University Of Thessaloniki (1)
Egypt (17) · United States (9) · Italy (6) · Spain (6) · Canada (4) · China (4) · Syria (4) · Germany (3) · Belgium (2) · Bulgaria (2) · France (2) · Greece (2) · India (2) · Israel (2) · Japan (2)
Abdul Hakim Nattouf, MD, PhD (4) · Marwan Alhalabi, MD, PhD (4) · Sally Kadoura, B Pharm, MD (4) · Ahmed Maged, MD (2) · Adolfo Allegra, MD (1) · Ahmed M Maged, MD (1) · Ahmed Maged (1) · Alex Polotsky, MD (1) · Allison M Case, MD FRCSC (1) · Angela R Baerwald, PhD (1)
PMID 109276, PMID 12536358, PMID 16672246, PMID 17555751, PMID 17854523, PMID 18765009, PMID 20637457, PMID 21273126, PMID 21371705, PMID 21563131, PMID 22197127, PMID 22819187, PMID 23394779, PMID 23809501, PMID 23958434, PMID 24129613, PMID 24608161, PMID 2492234, PMID 24929258, PMID 25956370, PMID 26207230, PMID 26460564, PMID 26945402, PMID 27060174, PMID 27428219, PMID 28062551, PMID 28825151, PMID 29132339, PMID 29320655, PMID 30407618, PMID 30927417, PMID 33011968, PMID 33495008, PMID 34808697, PMID 37276947, PMID 38272383, PMID 38498835, PMID 38521533, PMID 38723189, PMID 42819751, PMID 8062939
2004 (1), 2005 (1), 2017 (1), 2018 (1), R56HL114073 (1), U54HD058155 (1), UL1TR001082 (1)